A carregar...
Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
BACKGROUND: Congenital hyperinsulinism (CHI) is a rare and life-threatening genetic disorder. Sirolimus as a mammalian target of rapamycin inhibitor may be helpful in patients with CHI who do not respond well to other treatments including diazoxide and octreotide. However, the safety and efficacy of...
Na minha lista:
| Publicado no: | Int J Endocrinol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7396056/ https://ncbi.nlm.nih.gov/pubmed/32774365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7250406 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|